Maalaimalar is the famous No.1 tamil newspaper and Tamilnadu News with the local tamil news and latest tamil breaking news and e tamil news paper. Maalaimalar with the sections Cinema News, Sports News, Headlines, Online tamil songs, Tamil Daily, Aanmeegam, Health news, Videos new film videos and trailer, Historical news and MM application.
Phiten, the pioneer of AQUA-METAL™ materials and innovator of metal-infused technology, and professional baseball players C.J. Wilson, Josh Hamilton and J.B. Shuck have teamed up with Be The Match, the nonprofit organization dedicated to helping patients with blood cancers receive life-saving bone marrow and umbilical cord blood transplants. To support Be The Match and raise awareness of the national Be The Match Registry®, Phiten has designed a limited edition Phiten x Be The Match Tornado Necklace with sales benefiting the cause, and the three pro baseball players have been named Ambassadors of Hope by Be The Match.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64376-phiten-and-mlb-players-for-be-the-match-bone-marrow-donor-registry
There’s a dance that goes on between mothers and their newborns: the initiation of relationship and communication. However, current culturally driven health and child care practices are interrupting the dance and causing more harm than good. As a result, parents, especially first time parents, often require a great deal of education and support.
Dr. Barbara Morrison (DrBarb) is a certified nurse midwife dedicated to advocating, educating and inspiring healthcare reform for newborns and their families. As the founder and CEO of DrBarbCNM, LLC (http://www.DrBarbCNM.com), DrBarb is among the leading advocates of Kangaroo Care, the method of holding a newborn or infant skin-to skin, chest-to-chest to strengthen the bond between parent and child and to encourage breastfeeding and mental, social and physical development.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62882-close-up-talk-radio-recognizes-dr-barbara-morrison
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
Winter Remedies for Cold Weather:
Does the winter season left you with the sniffles? It's no surprise the damage the cold weather can do our lives, from sniffles to coughs, we experience it all!
Michelle Yarn provides some remedies for you to keep in mind this time of year. It's all about warmth!
Millennials, health-conscious shoppers and a shift in consumer palates set the stage for what’s to come in the food world this year according to Supermarket Guru, Phil Lempert. For 2014, Lempert, who works closely with ConAgra Foods, Inc. (NYSE: CAG) and its retailers, predicts that the most dramatic food changes will stem from the ever-changing consumer and their relationships with merchants, brands and food.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64398-conagra-food-trend-predictions
Approximately 1.5 million women and girls in the United States have epilepsy, of which nearly 500,000 are women of childbearing age. Treating women with epilepsy, especially women of childbearing age, presents significant challenges to physicians. Epilog.us [http://www.epilog.us], Upsher-Smith Laboratories, Inc’s [http://www.upsher-smith.com] epilepsy-focused educational website, discusses these challenges and provides professional insight by some of the epilepsy community’s most respected physicians including Dr. Cynthia Harden, Chief of the Comprehensive Epilepsy Care Center, North Shore University Hospital and Long Island Jewish Medical Center, and Dr. Christopher Skidmore, Director of Neurology Residency/Assistant Professor of Neurology, at Jefferson Medical College of Thomas Jefferson University.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59306-upsher-smith-epilog-website-challenges-in-managing-women-with-epilepsy
Starting today, your smart phone can make you smarter about your health. Cigna is launching a new mobile app to help customers take better control of their health and health spending.
Throughout 2013 Cigna will release upgraded app capabilities, including accurate pricing and quality information on doctors and hospitals for more than 200 medical procedures according to the real-time status of the customer’s health plan and available health account funds.
To view Multimedia News Release, go to http://www.multivu.com/players/English/59191-cigna-mobile-app/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Merck for Mothers has launched programs aimed at decreasing the number of women across the United States who die from or suffer severe complications related to pregnancy and childbirth.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62776-merck-for-mothers-working-to-reduce-maternal-mortality-rate
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today the launch of the WebMD Pregnancy app, a free iPhone® app offering expectant moms WebMD’s physician-reviewed pregnancy information that is customizable to fit a woman’s unique pregnancy. The WebMD Pregnancy App is WebMD’s latest addition to its multi-screen platform approach which provides actionable health information when consumers want it most, enabling them to better manage their health. WebMD is the leader in mobile for health information, with WebMD’s mobile apps for consumers having been downloaded over 16 million times.1
To view Multimedia News Release, go to http://www.multivu.com/mnr/60045-webmd-launches-new-pregnancy-app-for-iphone
1appFigures data through December 26, 2012; includes WebMD App, WebMD Baby App, WebMD Pain Coach App